Literature DB >> 33780110

Family physicians' awareness and general knowledge of hidradenitis suppurativa: A survey research.

Pelin Esme1, Gulsen Akoglu1, Oktay Sari2, Ercan Caliskan1.   

Abstract

RATIONALE, AIMS, AND
OBJECTIVE: Medical consultations of family physicians play a key role in early diagnosis and proper management of hidradenitis suppurativa (HS). This study aimed to investigate family physicians' disease awareness, general attitudes, and knowledge of HS. MATERIAL-
METHODS: This cross-sectional descriptive study was conducted with 211 family physicians and residents through a web-based survey. The questionnaire consisted of 25 questions about the demographic characteristics of the participants as well as their awareness and general knowledge of HS.
RESULTS: While 90% of physicians know that the diagnosis of HS is made clinically without any need for a laboratory examination, only 23.7% of them felt confident performing such a diagnosis. About 63% of participants defined HS as an infectious disease of the apocrine glands, contradictive to the real pathophysiology. About 21% of them had not been medically trained in HS, and 3% of them even had never heard the name of HS. Only 33% were aware of the role of biological agents. Most of the family physicians (57.4%) were willing to participate in postgraduate education programmes about HS.
CONCLUSION: The family physicians' awareness of HS is limited. Increased practice in medical education and postgraduate education programmes may help increase the knowledge of family physicians.
© 2021 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2021        PMID: 33780110     DOI: 10.1111/ijcp.14186

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  1 in total

1.  Communicating with health providers and romantic partners: The impact of negative emotions on quality of life for individuals with hidradenitis suppurativa.

Authors:  Natalie Ingraham; Lena R Hann; J Austin Williamson; Caleb Drew
Journal:  Int J Womens Dermatol       Date:  2022-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.